Roche delivers solid results in 2014
28 January 2015 | By Roche
Pharmaceutical giant Roche delivers its 2014 year-end results...
List view / Grid view
News
Screen time, not face time
28 January 2015 | By The Astellas Innovation Debate
British patients happy to have webcam consultations – especially the over 55s...
Sparse pipeline for acromegaly and gigantism treatment limiting market growth, says GlobalData
28 January 2015 | By GlobalData
The acromegaly and gigantism treatment market will expand at a modest Compound Annual Growth Rate (CAGR) of 3.74% from approximately $588 million in 2013 to $707 million by 2018, limited by a sparse pipeline, according to research and consulting firm GlobalData...
Bristol-Myers Squibb reports fourth quarter and full year 2014 financial results
Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the fourth quarter and full year of 2014, which were highlighted by strong global sales for priority brands and important advances in the company’s immuno-oncology (I-O) portfolio.
Provepharm launches ProveDye®, its first medical device, in Europe
28 January 2015 | By Andrew Lloyd & Associates
ProveDye is a new sterile solution of methylene blue designed to aid visualization in surgical procedures. With ProveDye, Provepharm extends the Proveblue® methylene blue compound product range...
Interoperable electronic health records can revolutionize healthcare delivery in Europe
27 January 2015 | By Frost & Sullivan
Country-specific EHR implementation strategies will expedite market development, says Frost & Sullivan...
Actavis to acquire Auden Mckenzie for £306m
27 January 2015 | By Actavis
Actavis plc and the owners of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK, announced that they have reached a definitive agreement, under which Actavis will acquire Auden Mckenzie for approximately…
Health data may not make your boss ‘app-y
27 January 2015 | By Lukats and Shapiro
Half of UK bosses tempted to snoop on employees health app data to catch them ‘pulling a sickie’...
The 2014 Euro Health Consumer Index
27 January 2015 | By Health Consumer Powerhouse
In spite of financial crisis, European healthcare keeps improving – but the equity gap widens...
Moberg Pharma’s fungal nail product approved in China
27 January 2015 | By Moberg Pharma
Moberg Pharma AB announced that its partner, Menarini Asia-Pacific, has received approval for Moberg’s fungal nail product in China...
New Cetraben® 3-in-1 emollient expands UK treatment options for people with dry skin conditions
26 January 2015 | By Pegasus
Research shows 87% of users prefer Cetraben® Ointment compared with other widely prescribed ointments...
New Additions to IONICON Trace Gas Analyzer Series to be showcased at Pittcon 2015
26 January 2015 | By IONICON
A fast GC add-on for PTR-TOFMS trace gas analyzers and the new PTR-QiTOF are now available...
Doctors fear that new health tech is turning UK into a nation of “worried well”
26 January 2015 | By Lukats and Shapiro
Doctors fear the wealth of health data from the internet and smartphones could be creating a new army of “worried well”, a survey for the Astellas Innovation DebateTM shows...
Santen receives a positive CHMP opinion for EU marketing authorization for Ikervis®
26 January 2015 | By NewCap.
Santen SAS announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the granting of a marketing authorization for Ikervis®...
Alliance Pharma appoints Nigel Clifford as an independent Non-Executive Director
26 January 2015 | By Alliance Pharma plc
Alliance Pharma plc has appointed Nigel Clifford as an independent Non-Executive Director of the Company. Nigel will join the Board with immediate effect.
